Cornerstone Investment Partners, LLC Zymeworks Inc. Transaction History

Cornerstone Investment Partners, LLC

  • $1.91 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021
SELL
$39.12 - $54.99 $429,342 - $603,515
-10,975 Closed
0 $0
Q2 2020

Jul 30, 2020
SELL
$33.67 - $40.0 $48,282 - $57,360
-1,434 Reduced 11.56%
10,975 $396,000
Q4 2019

Jan 29, 2020
BUY
$24.84 - $45.46 $308,239 - $564,113
12,409 New
12,409 $564,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $906M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email